<SEC-DOCUMENT>0001857044-24-000002-index.html : 20241004
<SEC-HEADER>0001857044-24-000002.hdr.sgml : 20241004
<ACCEPTANCE-DATETIME>20241004172150
ACCESSION NUMBER:		0001857044-24-000002
CONFORMED SUBMISSION TYPE:	D/A
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		<ITEMS>06b
FILED AS OF DATE:		20241004
DATE AS OF CHANGE:		20241004
EFFECTIVENESS DATE:		20241004

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Indaptus Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001857044
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				863158720
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-522181
		FILM NUMBER:		241355689

	BUSINESS ADDRESS:	
		STREET 1:		3 COLUMBUS CIRCLE
		STREET 2:		15TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		(646) 427-2727

	MAIL ADDRESS:	
		STREET 1:		3 COLUMBUS CIRCLE
		STREET 2:		15TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Intec Parent Inc.
		DATE OF NAME CHANGE:	20210414
</SEC-HEADER>
<DOCUMENT>
<TYPE>D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>